Page last updated: 2024-09-05

regadenoson and Vascular Diseases

regadenoson has been researched along with Vascular Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Aaronson, K; Colvin, M; Corbett, JR; Ghannam, M; Koelling, T; Konerman, MC; Lazarus, JJ; Murthy, VL; Pagani, F; Saleh, A; Weinberg, RL	1
Botvinick, EH; Gullberg, GT; Pampaloni, MH; Sciammarella, M; Seo, Y; Shrestha, UM	1
Campigotto, F; Field, JJ; Keefer, J; Lin, G; Linden, J; Majerus, E; Nathan, DG; Neuberg, D; Okam, MM; Onyekwere, O; Ross, A	1

Trials

1 trial(s) available for regadenoson and Vascular Diseases

Article	Year
Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood, 2013, Apr-25, Volume: 121, Issue:17 Topics: Adenosine A2 Receptor Agonists; Adult; Anemia, Sickle Cell; Case-Control Studies; Female; Flow Cytometry; Humans; Infusions, Intravenous; Interferon-gamma; Male; Natural Killer T-Cells; Phosphorylation; Prognosis; Purines; Pyrazoles; Receptor, Adenosine A2A; Tissue Distribution; Transcription Factor RelA; Vascular Diseases	2013

Article

Year

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

Blood, 2013, Apr-25, Volume: 121, Issue:17

Topics: Adenosine A2 Receptor Agonists; Adult; Anemia, Sickle Cell; Case-Control Studies; Female; Flow Cytometry; Humans; Infusions, Intravenous; Interferon-gamma; Male; Natural Killer T-Cells; Phosphorylation; Prognosis; Purines; Pyrazoles; Receptor, Adenosine A2A; Tissue Distribution; Transcription Factor RelA; Vascular Diseases

2013

Other Studies

2 other study(ies) available for regadenoson and Vascular Diseases

Article	Year
Safety of regadenoson positron emission tomography stress testing in orthotopic heart transplant patients. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:3 Topics: Adenosine; Aged; Blood Pressure; Electrocardiography; Exercise Test; Female; Heart Transplantation; Hemodynamics; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Patient Safety; Positron-Emission Tomography; Purines; Pyrazoles; Retrospective Studies; Risk Factors; Stress, Mechanical; Transplant Recipients; Vascular Diseases	2020
Noninvasive PET quantitative myocardial blood flow with regadenoson for assessing cardiac allograft vasculopathy in orthotopic heart transplantation patients. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Coronary Circulation; Female; Heart Transplantation; Humans; Male; Middle Aged; Positron-Emission Tomography; Purines; Pyrazoles; Transplantation, Homologous; Vascular Diseases	2017

Article

Year

Safety of regadenoson positron emission tomography stress testing in orthotopic heart transplant patients.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020, Volume: 27, Issue:3

Topics: Adenosine; Aged; Blood Pressure; Electrocardiography; Exercise Test; Female; Heart Transplantation; Hemodynamics; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Patient Safety; Positron-Emission Tomography; Purines; Pyrazoles; Retrospective Studies; Risk Factors; Stress, Mechanical; Transplant Recipients; Vascular Diseases

2020

Noninvasive PET quantitative myocardial blood flow with regadenoson for assessing cardiac allograft vasculopathy in orthotopic heart transplantation patients.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2017, Volume: 24, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Coronary Circulation; Female; Heart Transplantation; Humans; Male; Middle Aged; Positron-Emission Tomography; Purines; Pyrazoles; Transplantation, Homologous; Vascular Diseases

2017